In October 2023 and again in May 2024, the FDA issued consumer warnings specifically about compounded semaglutide, noting reports of adverse events including hospitalizations linked to dosing errors and unlicensed products [2]
The hidden cost of GLP-1s: Popularity surge raises long-term affordability questions CHICAGO - As the use of GLP-1s has surged across the United States, the average total payments per user have also climbed sharply, a new study reveals
This substantial quantity allows for extended studies and multiple experimental phases without the need for frequent reordering
Interestingly, this was a symptom mainly noticed by men, who reported feeling weaker and less athletic, in contrast to women, who were more likely to notice excess weight gain and feel more squishy. Additional related issues that were commonly reported included pain , fibromyalgia , and carpal tunnel
Headache: Stay hydrated and take rest as much as possible